Creatine kinase in prostate cancer: A biosensor-driven diagnostic paradigm.
Innovative CK-BB biosensors show over 85% accuracy in prostate cancer detection! ⚗️📊 Rapid, sensitive diagnostics on the horizon!
“We will develop health and technology together.
In this way, we have broken our tails and determined our route, and we are a comet that shines brightly and we will illuminate each other. “
Yusuf Yesil, M.D.
Founder of Yesil Science
Would you like to get closer to our young team with a wide background from engineering to life science and art ?Join us in our dream of combining medicine, art, and technology. Let's work online together.
It is a community open to everyone who wants to be together with us in our dream of bringing together medicine, technology and art, and to be in active communication with Yesil Science in our ecosystem.
Innovative CK-BB biosensors show over 85% accuracy in prostate cancer detection! ⚗️📊 Rapid, sensitive diagnostics on the horizon!
AI model enhances delirium detection in hospitals, improving patient outcomes by increasing identification rates and enabling timely treatment. 🏥🤖
Radiomics differentiates UTUC from RCC with 88.4% sensitivity. Machine learning enhances preoperative CT diagnostics. 📊🩺